Centessa Pharmaceuticals Financial Overview
Centessa Pharmaceuticals's market cap is currently $3.18B. The company's EPS TTM is $-0.41; its P/E ratio is -13.02; Centessa Pharmaceuticals is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.39. See an overview of income statement, balance sheet, and cash flow financials.
